In the latest trading session, 0.43 million Aptose Biosciences Inc (NASDAQ:APTO) shares changed hands as the company’s beta touched 1.26. With the company’s most recent per share price at $0.48 changed hands at -$0.01 or -1.96% at last look, the market valuation stands at $8.61M. APTO’s current price is a discount, trading about -879.17% off its 52-week high of $4.70. The share price had its 52-week low at $0.40, which suggests the last value was 16.67% up since then. When we look at Aptose Biosciences Inc’s average trading volume, we note the 10-day average is 66980.0 shares, with the 3-month average coming to 76.13K.
Analysts gave the Aptose Biosciences Inc (APTO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended APTO as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Aptose Biosciences Inc’s EPS for the current quarter is expected to be -1.19.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Instantly APTO was in red as seen in intraday trades today. With action -1.10%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -81.27%, with the 5-day performance at -1.10% in the red. However, in the 30-day time frame, Aptose Biosciences Inc (NASDAQ:APTO) is -22.63% down. Looking at the short shares, we see there were 91202.0 shares sold at short interest cover period of 1.16 days.
Aptose Biosciences Inc (APTO) estimates and forecasts
Data shows that the Aptose Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -74.15% over the past 6 months, a 65.44% in annual growth rate that is considerably higher than the industry average of 18.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 10.18%. The 2024 estimates are for Aptose Biosciences Inc earnings to increase by 65.44%.
APTO Dividends
Aptose Biosciences Inc is expected to release its next quarterly earnings report in September.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 17.11% of Aptose Biosciences Inc shares while 15.16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 18.29%. There are 15.16% institutions holding the Aptose Biosciences Inc stock share, with DOHENY ASSET MANAGEMENT /CA the top institutional holder. As of 2024-06-30, the company held 0.3849% of the shares, roughly 50550.0 APTO shares worth $0.32 million.
CALDWELL SUTTER CAPITAL, INC. holds the second largest percentage of outstanding shares, with 0.0007% or 92.0 shares worth $70.0 as of 2024-06-30.
